Silva Pharmaceuticals Limited (DSE:SILVAPHL)
Bangladesh
· Delayed Price · Currency is BDT 8.90
-0.50 (-5.32%)
At close: Mar 8, 2026
Silva Pharmaceuticals Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Net Income | -145.41 | -132.95 | -64.48 | 33.08 | 102.26 | 119.85 | Upgrade
|
| Depreciation & Amortization | 56.29 | 59.11 | 60.45 | 65.93 | 68.12 | 70.73 | Upgrade
|
| Other Amortization | 0.25 | 0.19 | 0.14 | 0.15 | 0.17 | 0.16 | Upgrade
|
| Other Operating Activities | 9.04 | 8.77 | 7.06 | -1.86 | -11.12 | 3.29 | Upgrade
|
| Change in Accounts Receivable | 35.06 | 26.51 | 3.19 | -1.71 | 14.6 | -8.79 | Upgrade
|
| Change in Inventory | 54.23 | 50.19 | 0.52 | -11.43 | -18.11 | -19.8 | Upgrade
|
| Change in Accounts Payable | 3.61 | 2.81 | 0.17 | 0.09 | 0.64 | -0.29 | Upgrade
|
| Change in Other Net Operating Assets | -4.74 | -1.07 | -3.63 | -14.15 | 4.3 | -5.76 | Upgrade
|
| Operating Cash Flow | 8.32 | 13.56 | 3.42 | 70.1 | 160.85 | 159.4 | Upgrade
|
| Operating Cash Flow Growth | - | 296.57% | -95.12% | -56.42% | 0.91% | 5.83% | Upgrade
|
| Capital Expenditures | -4.99 | -7.07 | -32.99 | -86.81 | -177.64 | -77.18 | Upgrade
|
| Investment in Securities | -52.63 | 24.77 | 63.92 | 72.32 | -13.38 | -8.63 | Upgrade
|
| Investing Cash Flow | -57.63 | 17.7 | 30.93 | -14.49 | -191.02 | -85.82 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 61.87 | 2.46 | Upgrade
|
| Total Debt Issued | 1.04 | - | - | - | 61.87 | 2.46 | Upgrade
|
| Short-Term Debt Repaid | - | -19.49 | -8.13 | -35.17 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -1.7 | -2.24 | -3.2 | -6.18 | -6.49 | Upgrade
|
| Total Debt Repaid | -9.37 | -21.19 | -10.37 | -38.37 | -6.18 | -6.49 | Upgrade
|
| Net Debt Issued (Repaid) | -8.33 | -21.19 | -10.37 | -38.37 | 55.69 | -4.04 | Upgrade
|
| Common Dividends Paid | -9.86 | -9.99 | -13.93 | -25.03 | -47.75 | -47.3 | Upgrade
|
| Financing Cash Flow | -18.19 | -31.18 | -24.3 | -63.4 | 7.94 | -51.34 | Upgrade
|
| Net Cash Flow | -67.49 | 0.08 | 10.05 | -7.78 | -22.24 | 22.25 | Upgrade
|
| Free Cash Flow | 3.33 | 6.49 | -29.57 | -16.7 | -16.8 | 82.22 | Upgrade
|
| Free Cash Flow Margin | 0.93% | 1.69% | -4.93% | -2.33% | -2.16% | 10.29% | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.05 | -0.22 | -0.12 | -0.12 | 0.60 | Upgrade
|
| Cash Interest Paid | 4.86 | 4.11 | 3.63 | 2.73 | 4.06 | 1.74 | Upgrade
|
| Cash Income Tax Paid | 4.47 | 5.06 | 11.76 | 20.28 | 26.23 | 29.26 | Upgrade
|
| Levered Free Cash Flow | 52.56 | 59.92 | -1.92 | -28.2 | -48.45 | 53.24 | Upgrade
|
| Unlevered Free Cash Flow | 55.76 | 62.73 | 0.82 | -25.94 | -45.5 | 54.98 | Upgrade
|
| Change in Working Capital | 88.15 | 78.44 | 0.26 | -27.19 | 1.43 | -34.63 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.